Mylan Laboratories Limited Sitagliptin Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Sitagliptin Export Records India — #3 Exporter, 233 Shipments, $7.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sitagliptin

India Pharmaceutical Trade Intelligence

$75.8M309 Suppliers121 CountriesHS 30049099

ExportsIndia → CANADA11.6%India → MEXICO11.1%

ImportsCANADA → India$43.8K NETHERLANDS → India$23.2K

#1 Buyer: YILMAZ TRANSPORT

Mylan Laboratories Limited — Sitagliptin Exporter #3 | $7.0M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Sitagliptin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Sitagliptin · $7.0M export value · DGFT Verified

Mylan Laboratories Limited is the #3 Indian exporter of Sitagliptin with $7.0M in export value and 233 verified shipments. Mylan Laboratories Limited holds a 9.2% market share in Sitagliptin exports across 10 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Sitagliptin Export Profile: Buyers & Destinations

Mylan Laboratories Limited Sitagliptin export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Sitagliptin?

Country	Value	Shipments	Share
NETHERLANDS	$2.0M	107	42.7%
FRANCE	$1.0M	25	22.1%
MALTA	$913.5K	46	19.7%
ITALY	$408.7K	17	8.8%

Who Are the Top Buyers of Sitagliptin from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$1.2M	57
XXLANXXRELXXD LXXITEXX NEXXNHAXXCOUXX MXXAHIXX RO	FRANCE	$759.0K	36
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$444.6K	10
M/S. CSP MYLAN SAS AT CSP LABO 2744	MALTA	$250.0K	5
M/S. ALLOGA WAREHOUSE,	MALTA	$241.0K	17
MYLAN ITALIA S.R.L.,	ITALY	$236.1K	11
VIATRIS PHARMACEUTICALS SL,	SPAIN	$207.2K	16
M/S. MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$163.3K	10
M/S. ALLOGA UK,	MALTA	$157.4K	4
M/S. PHARMLOG,	MALTA	$123.1K	5

Mylan Laboratories Limited supplies Sitagliptin to 35 buyers globally. The largest buyer is MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), followed by XXLANXXRELXXD LXXITEXX NEXXNHAXXCOUXX MXXAHIXX RO (FRANCE) and CSP MYLAN SAS AT CSP LABO 274 (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sitagliptin Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
HARMLESS MEDICINES, SITAGLIPTIN MYLAN 10	$626.0K	19
SITAGLIPTIN MYLAN 100 MG 28 BL TAB PACKS	$313.6K	12
SITAGLIPTINE VIATRIS 100 MG 28BL TAB PAC	$213.9K	5
SITAGLIPTIN TAB 100 MG 28 BL FR VIA PACK	$200.0K	4
HARMLESS MEDICINES, SITAGLIPTINA MYLAN 1	$189.4K	4
SITAGLIPTINE VIATRIS 50 MG 28BL TAB	$167.7K	4
SITAGLIPTINE VIATRIS 100 MG 28 BL TAB PA	$150.0K	3
SITAGLIPTIN TAB 50MG 28BL IT MY	$101.6K	3
SITAGLIPTIN TAB 100 MG 28 BL UK MY PACKS	$100.0K	2
HARMLESS MEDICINES, SITAGLIPTINE VIATRIS	$100.0K	2

Mylan Laboratories Limited exports 128 distinct Sitagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES, SITAGLIPTIN MYLAN 10 with 19 shipments worth $626.0K.

How Does Mylan Laboratories Limited Compare to Nearest Sitagliptin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DR.REDDY'S LABORATORIES LTD	$7.7M	243	8	$31.9K
3	MYLAN LABORATORIES LIMITED ★	$7.0M	233	10	$30.0K
2	SANDOZ PRIVATE LIMITED	$6.5M	129	6	$50.0K
7	AUROBINDO PHARMA LTD	$4.3M	216	4	$20.1K

Mylan Laboratories Limited ranks #3 among 309 Indian Sitagliptin exporters. Average shipment value of $30.0K compared to the market average of $149.3K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and SANDOZ PRIVATE LIMITED.

Which Indian Ports Ship Sitagliptin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	772	14.4%
DELHI AIR CARGO ACC (INDEL4)	739	13.8%
SAHAR AIR	735	13.7%
DELHI AIR	513	9.6%
NHAVA SHEVA SEA (INNSA1)	217	4.0%
HYDERABAD AIR	213	4.0%
Bombay Air	196	3.7%
HYDERABAD ACC (INHYD4)	191	3.6%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Sitagliptin Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 233 individual customs records matching Mylan Laboratories Limited exporting Sitagliptin, covering 128 formulations to 10 countries via 35 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 575+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sitagliptin

Sitagliptin

Mylan Laboratories Limited — Sitagliptin Exporter Profile

Mylan Laboratories Limited — Sitagliptin Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Sitagliptin?

Who Are the Top Buyers of Sitagliptin from Mylan Laboratories Limited?

What Is India's Total Sitagliptin Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Sitagliptin Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Sitagliptin Exporters?

What Sitagliptin Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Sitagliptin Exporters?

Which Indian Ports Ship Sitagliptin Exports?

Sitagliptin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Sitagliptin Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sitagliptin Export Data from Mylan Laboratories Limited

Sitagliptin Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source